. Characterization of the different DC types used in this study. BMDCs were 1) . Uptake of different phagocytic cargo. Resting and LPS-treated BMDCs were allowed to internalize OVA-expressing, PKHgreen-labeled E.coli, which were alive (A), fixed by paraformaldehyde treatment (B) or heat-killed (C), as well as OVA-expressing and UVC-irradiated MEFs (D; bm1-OVA) for 30 min pulse and 60 min chase. UVC-induced cell death of bm1-OVA cells was confirmed by SytoxBlue labeling (green in D). Subsequently, BMDCs were fixed, labeled for LAMP-1 (red), F-actin (grey) and DNA (blue) and analyzed by confocal microscopy. Shown are maximum projections of representative cells of two independent experiments. The bar represents 10 µm. 2 and 4) . LPS-treated BMDCs are delayed in phagosome maturation, which is dependent on the duration of LPS treatment. Lysosomes of BMDCs were pre-loaded with fluorescent wheat germ agglutitin (WGA) prior phagocytosis of bbOVA. Phagosomal degradation of OVA (A) as well as phagosomal acquisition of WGA (B), LAMP-1 (C) and LAMP-2 (D) were analyzed by flow organellocytometry after different chase periods. BMDCs were treated for 16 h with 10 ng/ml or 100 mg/ml of LPS and and labeled for expression of co-stimulatory molecules and MHC II molecules on the surface of CD11c + cells (E) before phagocytic uptake of bbOVA. In these DCs, degradation of phagosomal OVA and acquisition of LAMP-1 were analyzed over time by flow organellocytometry (F). BMDCs were also treated with 100 ng/ml LPS for different time periods (6 h, 12 h, 24 h, 36 h) and then analyzed for DC maturation markers on the surface of CD11c + cells (G) as well as for degradation of phagosomal OVA and acquisition of LAMP-1 (H) as described above. Shown is one representative example of at least two independent experiments. Table 1 ). Shotgun proteomics and western blotting of DC phagosomes. Workflow of the applied quantitative shotgun approach (A). Phagosomes of resting and LPS-treated BMDCs were purified after OVA-coupled beads were internalized (30 min pulse and 60 min chase). Subsequently, phagosomes were lysed and precipitated. The phagosomal precipitates were digested by endoproteinase Lys-C and labeled with light ( 12 C 3 ) and heavy ( 13 C 3 ) N-hydroxysuccinimide propionate, respectively. Equal amounts of both labeled digests were mixed followed by LC-MS/MS analysis. Note that the labeled peptides result in a mass difference of six Dalton (Da) between light and heavy peptides. m/z: mass-to-charge ratio. Histograms showing distribution and abundance of identified phagosomal proteins in replicates 1 (left) and 2 (right) including 95% confidence intervals of identification (B). See extended experimental procedures for more information. Similarly, OVAcoupled latex bead phagosomes (LBP) were isolated after 30 min pulse and 60 min chase and analyzed by SDS-PAGE and western blotting. LBP were analyzed together with total cell lysates (TCL) for presence of the indicated proteins (C). In each lane, 30 µg of protein were loaded. Below, proteins are listed that are involved in antigen processing and presentation that were identified by LC-MS/MS in two independent experiments (repl. 1 and 2) including their fold change (D). Values above 2.02 (replicate 1) and 2.67 (replicate 2) represent enrichment in phagosomes of resting BMDCs (orange), while values below -1.52 (replicate 1) and -1.63 (replicate 2) show enrichment in phagosomes of LPS-treated BMDCs (blue). 2 and 4) . Alternative maturation stimuli trigger different responses in BMDCs. Phenotype of BMDCs in resting condition and after 16 h treatment with different TLR agonists (100 ng/ml LPS, 60 ng/ml R848, 5 µM CpG) (A-D) and 200 ng/ml TNF (E-F). Maturation of BMDCs (A, E) and degradation of phagosomal OVA (B, F) were analyzed by flow cytometry. BMDCs were also fixed, labeled for LAMP-1 (red), F-actin (green) and DNA (blue) and analyzed by confocal microscopy (C, G). Additionally, intracellular areas of BMDCs treated with different TLR agonists were quantified for their relative LAMP-1 + areas (cell number >30 for each analyzed condition) (D). Shown are representative examples of two independent experiments. Error bars represent SD. Bars represent 10 µm. 5 and 6) . Analysis of Rab34 silenced BMDCs. Cells were transfected with scramble siRNA (control) and different Rab34 siRNA clones (from #1 to #4). Expression of cell surface CD11b and CD11c (A) as well as of co-stimulatory molecules and MHC II molecules analyzed by flow cytometry are shown for control and siRNA #4. Silencing efficiency of Rab34 was tested and quantified by western blotting (C). Error bars represent SD. BMDCs were incubated for 16 h in presence or absence of 100 ng/ml LPS before bbOVA were phagocytosed. Phagosomal degradation of OVA (D) as well as phagosomal acquisition of LAMP-1 (E) were analyzed in control cells and BMDCs transfected with Rab34 siRNA #1 and #4 by flow organellocytometry after different chase periods. Shown is one representative example of three independent experiments.
Supplemental Experimental Procedures
Mice and Cells C57BL/6 mice and C57BL/6 recombination activating gene 1-deficient OT-I TCR (Vα2, Vβ5) transgenic mice were obtained from Charles River Laboratories, Janvier and Centre de Distribution, Typage et Archive Animal (CDTA, Orleans, France). Mice were used between 6-10 weeks old. All animal procedures were in accordance with the guidelines and regulations of the French Veterinary Department or were approved by the animal ethical committee of Ghent University, Belgium.
Bone marrow-derived DCs were produced by culture in GM-CSF-containing medium: IMDM (SigmaAldrich, Life Technologies) containing 10% heat-inactivated FBS (Biowest), 100 IU/ml penicillin, 100 µg/ml streptomycin, 2 mM Glutamax (all from Life Technologies), and 50 µM β-mercaptoethanol (Sigma-Aldrich, Life Technologies). Supernatant from J558 plasmacytoma cells was used as GM-CSF source (Winzler et al., 1997) . Bone marrow-derived macrophages were generated by culture in M-CSF-containing medium: RPMI-1640 (Life Technologies) containing 10% heat-inactivated FBS (Biowest), 100 IU/ml penicillin, 100 µg/ml streptomycin, 2 mM Glutamax (all from Life Technologies), and 50 µM β-mercaptoethanol (Sigma, Life Technologies). Supernatant from L929 hybridoma cells was used as M-CSF source (Stanley and Heard, 1977) . OVA-expressing H2 bm1 transformed mouse embryonic fibroblasts (kindly provided by Caetano Reis E Sousa; Sancho et al., 2009 ) were grown in DMEM (Life Technologies) containing 10% heat-inactivated FBS (Biowest) supplemented with non-essential amino acids, Glutamax and sodium pyruvate (all fom Life Technologies). Cell death was induced by irradiation with 480 mJ UVC per cm 2 using the CL-1000 Ultraviolet Crosslinker (UVP). CD8 + OT-I T cells specific for the SIINFEKL peptide in H-2Kb MHC class I context were obtained from lymph nodes of OT-I mice and isolated using negative selection (Miltenyi Biotec) in accordance with the manufacturer's instructions.
To prepare splenic DCs, each mouse spleen was injected with 2 ml of a digestion solution: 0.1 mg/ml Liberase (Roche), 0.1 mg/ml DNase I (Roche), 1x PenStrep in RPMI-1640 (both from Life Technologies); cut into small pieces and incubated for 25 min at 37°C. Reaction was stopped by addition of complete medium. Spleens were passed through a cell strainer and centrifuged at 200 x g for 5 min. After red blood cell lysis (Sigma-Aldrich, Lonza), splenic DCs were isolated performing two consecutive rounds of positive selection using CD11c microbeads (Miltenyi Biotec) according to the manufacturer's instructions. In all experiments, purity of cells was above 90%. Cell culture and activation was performed as described for BMDCs. Maturation of cells was induced by a 16 h treatment with 100 ng/ml of ultrapure LPS from E. coli 0111:B4 (Invivogen) unless otherwise stated. DC maturation was controlled by cell surface expression of co-stimulatory molecules and MHC II molecules using specific antibodies.
Material and Buffers
The following reagents and materials were used: low endo OVA (50 mg/mL stock, Worthington Biochemicals); 1 µm and 3 µm amino beads and 3 µm dyed polybeads (all from Polysciences); OVA peptide 257-264 (SIINFEKL) (Polypeptide Group); ultrapure LPS from E. coli 0111:B4, R848, CpG ODN2395 (all from Invivogen); MegaCD40L (Enzo Life Sciences); recombinant mTNF (PSF, Inflammation Research Center, Ghent); wheat germ agglutinin (WGA) coupled to Alexa Fluor 647 (Life Technologies); CO 2 -independent medium (Life Technologies); protease inhibitor cocktail (Roche); poly-L-lysine (Life Technologies) and cytochrome C from equine heart (Sigma-Aldrich).
Antibodies and Dyes
The following antibodies and dyes were used: purified rabbit polyclonal anti-OVA (Sigma-Aldrich), antibodies for cell surface staining and/or phenotype analysis (CD11c, CD11b, CD40, CD80, CD86, MHC I, MHC II, TCR Vα2, Vβ5, CD8, CD4, CD25, CD69) were purchased from BD Pharmingen and eBiosciences. Biotin anti-LAMP-1 and LAMP-2 were purchased from eBiosciences. Additionally, purified antibodies against Rab34, LAMP-1 (both from Abcam), Ykt6 and Calnexin (both from Santa Cruz) and against Rab7 and Cathepsin D (both from Cell Signaling) were used. HRP-coupled antibody (Jackson Laboratories) was used in western blot analysis. Anti-species conjugated to Alexa 488, 568 or 647 and Alexa 488 and 647 NHS ester dyes were all from Life Technologies. Hoechst, SytoxBlue and Phalloidin labeled with Alexa 647, Alexa 488 or Alexa 555 were purchased from Life Technologies. PKH67 Green Fluorescent Cell Linker was from Sigma-Aldrich.
In vivo maturation of DCs
Different doses of ultrapure LPS, E. coli 0111:B4 (Invivogen), were injected intraperitoneally into 8-10 weeks old C57BL/6 mice, in order to find a proper dose to provide maximum levels of DCs activation judged by upregulation of co-stimulatory molecules (CD40, CD86), but the lowest associated pathogenesis. 1, 10, 20 and 50 µg were tested, being 10 µg the best amount fulfilling all of the afore-mentioned requisites. Sterile, endotoxinfree PBS was always used for control injections. The total time for DC maturation was 16 h of treatment, but 12 h was also assessed without any significant difference (data not shown).
In vitro Cross-presentation Assays
DCs were incubated with 3 µm beads coated with different ratios of OVA and BSA proteins (OVA 10 mg/ml alone; OVA 2.5 mg/ml-BSA 7.5 mg/ml; OVA 5 mg/ml-BSA 5 mg/ml and BSA 10 mg/ml alone) or different concentrations of the control minimal peptide (OVA SIINFEKL). After 1 h, DCs were washed three times with PBS containing 0.1% (vol/vol) BSA and co-cultured with purified CFSE-OT-I CD8 + for 3 days. For monitoring T cell proliferation, diminution of CFSE staining on TCR + CD8 + populations was measured by flow cytometry. Alternatively, DCs were incubated for 5 h with different concentrations of soluble OVA, 3 µm beads coated with different ratios of OVA and BSA proteins (as mentioned before), or with the minimal peptide SIINFEKL at different concentrations as control of surface MHC class I amount. After this time, cells were washed three times with 0.1% (vol/vol) PBS/BSA, fixed with 0.008% (vol/vol) glutaraldehyde during 10 min at 4°C, washed twice with 0.2 M glycine and once with 0.1% (vol/vol) PBS/BSA, and finally B3Z hybrid T cells were added. After 16 h, T cell activation was measured detecting β-galactosidase activity by optical density at 590 nm using chlorophenol red-β-D-galactopyranoside (CPRG) as substrate for the reaction. Furthermore, cross-presentation was also evaluated by the capacity of DCs to activate CD8 + T cells. T cells were co-cultured with fixed DCs. CD69 marker expression was measured by flow cytometry after 16 h of co-culture.
In vivo Cross-presentation Assays
Three different forms of OVA were administered by intravenous injection: soluble OVA, OVA immune complexes and bead-bound OVA. For bead-bound OVA, LPS was injected 14 hours prior to experiments, followed by i.v. (retro-orbital) injection of beads and 2 more hours of dissemination and phagocytosis, for a total of 16 h of maturation. Subsequently, spleens were harvested and digested by a solution composed of 0.1 mg/ml Liberase (Roche), 0.1 mg/ml DNase I (Roche), 1x PenStrep in RPMI-1640 (Life Technologies). Then, they were cut into small pieces and incubated for 25 min at 37°C. The reaction was stopped by addition of complete medium. Spleens were passed through a cell strainer and centrifuged at 200 x g for 5 min. After red blood cell lysis (Sigma-Aldrich), splenic DCs were isolated by a first round of CD11c negative selection (panDC purification, Miltenyi) followed by FACS sorting (see next section) on CD8 + DCs that had phagocytosed at least 1 bead. For soluble OVA and OVA immune complexes, LPS was injected 15.5 h prior to experiments, and the antigen was administered i.v. for 30 min. Again, spleens were collected and processed as indicated, followed by 2 rounds of CD11c negative selection (in all experiments, purity was higher than 80%). DCs were then cocultured with OT-I T cells for 16 h and activation of T cells was addressed by CD25 and CD69 staining.
Sorting of CD8
+ DCs for in vivo Cross-presentation Assay CD11c + pre-sorted DCs were incubated with antibodies against CD16/CD32 (Fc Block, BD Biosciences) for 15 min at 4°C, washed twice at 300 x g for 5 min before being incubated with antibodies against CD8a and CD11c (BD Biosciences) for 30 min at 4°C. Stained cells were washed twice, filtered using a 35 µm cell strainer (Corning) and resuspended in PBS-BSA 0.1% (vol/vol) before proceeding to cell sorting using a FACSAria II (BD Biosciences). Gates were set on populations of CD8a + , CD11c + and CD8a -, CD11c + DCs, which contained at least one fluorescent bead per cell.
Phagocytosis Assays
Uptake efficiency was analyzed as described previously (Hoffmann et al., 2012) . Briefly, amine-modified beads (3 µm diameter) were washed twice in PBS. Afterwards, beads were pre-activated with 8% (vol/vol) glutaraldehyde in PBS for 4 h at room temperature under tilt rotation and protected from light. Subsequently, beads were washed in PBS and conjugated overnight at 4°C to 0.5 mg/ml OVA and 0.1 mg/ml Alexa Fluor 488. Beads were quenched with 0.5 M glycine in PBS for 30 min at 4°C and washed twice in PBS. BMDCs were collected from culture dishes, washed once in PBS, and resuspended in CO 2 -independent medium (Life Technologies) at a density of 20×10 6 cells/ml. Phagocytic binding of OVA-and Alexa 488-coated beads to the cell suspension was performed for 15 min on ice at a bead:cell ratio of 15:1. Unbound beads were removed by three washes in cold PBS. Subsequently, cells were incubated in complete medium for different periods of chase at 37°C and 5% CO 2 . Phagocytic uptake was stopped by the addition of ice-cold PBS and two washes in PBS. To distinguish external from internalized beads, samples were labeled with rabbit anti-ovalbumin antibody and a fluorescently labeled secondary antibody (goat anti-rabbit Alexa 647). Samples were measured by flow cytometry using the LSR II cytometer (BD Biosciences).
GFP-and OVA-expressing E.coli were used alive, fixed for 20 min with 4% (vol/vol) paraformaldehyde or heat-killed for 20 min at 60°C. UVC-irradiated H2 bm1 transformed mouse embryonic fibroblasts were added to BMDCs at a ratio of 20:1. After 30 min pulse and 60 min chase at 37°C, BMDCs were fixed, labeled and analyzed by confocal microscopy.
Mass Spectrometry Analysis
DC phagosomes containing 1 µm OVA-coupled beads were isolated after 30 min pulse and 60 min chase as described elsewhere (Hoffmann et al., 2010) . Phagosomes were lysed in 1 % (vol/vol) Triton X-100, 50 mM Tris, pH 8.0, 10 mM DTT, 2x protease inhibitor cocktail for 15 min on ice. Phagosomal lysates were precipitated in acetone at -20°C overnight. Protein pellets were washed three times with ice-cold acetone and dissolved in 1 ml of 20 mM triethylammonium bicarbonate, pH 7. The protein concentration was measured using the Micro BCA Protein Assay Kit (Thermo Scientific). Protein mixtures were digested overnight at 37°C with endoproteinase Lys-C (1/10, w/w, Boehringer Mannheim), after which the resulting peptides were postmetabolically labeled using N-hydroxysuccinimide esters of either 12 C 3 -propionate (samples: resting BMDCs) or 13 C 3 -propionate (samples: LPS-treated BMDCs) (Ghesquière et al., 2011) . Equal amounts of peptide samples were then mixed and prior to LC-MS/MS analysis, the peptide mixtures were pre-fractionated by RP-HPLC into 20 different fractions (Holmberg et al., 2013) .
The obtained peptide mixtures were introduced into an LC-MS/MS system, the Ultimate 3000 RSLC nano (Dionex) in-line connected to an LTQ-Orbitrap Velos (Thermo Fisher Scientific) for analysis. The sample mixture was loaded on a trapping column (made in-house, 100 µm internal diameter (I.D.) x 20 mm, 5 µm beads C18 Reprosil-HD, Dr. Maisch, Ammerbuch-Entringen, Germany). After flushing from the trapping column, the sample was loaded on a reverse-phase column (made in-house, 75 µm I.D. x 150 mm, 3 µm beads C18 Reprosil-HD, Dr. Maisch). Peptides were loaded with solvent A (0.1% trifluoroacetic acid, 2% acetonitrile) and separated with a linear gradient from 98% solvent A' (0.1% formic acid) and 2% solvent B' (0.1% formic acid and 80% acetonitrile) to 55% solvent B' over 30 min at a flow rate of 300 nl/min followed by a wash reaching 97% solvent B'. The mass spectrometer was operated in data-dependent mode, automatically switching between MS and MS/MS acquisition for the ten most abundant peaks in a given MS spectrum. In the LTQ-Orbitrap Velos, full scan MS spectra were acquired in the Orbitrap at a target value of 1E6 with a resolution of 60,000. The ten most intense ions were then isolated for fragmentation in the linear ion trap, with a dynamic exclusion of 30 s. Peptides were fragmented after filling the ion trap at a target value of 1E4 ion counts.
From the MS/MS data in each LC run, Mascot Generic Files (mgf) were created using the Distiller software (version 2.5.1.0, Matrix Science). When generating these peak lists, grouping of spectra was allowed in Distiller with a maximal intermediate retention time of 30 s and a maximum intermediate scan count of 5 was used (whenever possible). Grouping was done with 0.005 Th precursor tolerance. A peak list was only generated when the MS/MS spectrum contained more than 10 peaks. There was no de-isotoping and the relative signal-tonoise limit was set at 2. These peak lists were then searched using the Mascot search engine with the Mascot Daemon interface (version 2.5.0, Matrix Science). Spectra were searched against the Swiss-Prot database (version 2014-12-01) with a taxonomy filter on Mus musculus. Variable modifications were set to pyroglutamate formation of amino-terminal glutamine and acetylation of the protein N-terminus. Methionine oxidation was set as a fixed modification. Labeling was configured allowing for light ( 12 C 3 -propionate) or heavy ( 13 C 3 -propionate) labels at peptide N-termini and lysine side-chains. This setting was configured in exclusive mode. Mass tolerance on precursor ions was set to ± 10 ppm (with Mascot's 13 C option set to 1), and on fragment ions to ± 0.5 Da. The peptide charge was set to 1+, 2+, 3+ and the instrument setting was on ESI-TRAP. The enzyme was set to endoproteinase Lys-C, allowing for 1 missed cleavage, and cleavage was also allowed when lysine is followed by proline. Only peptides that were ranked one and scored above the threshold score, set at 99% confidence, were withheld. All peptide spectrum matches matching peptides shorter than 8 amino acids were rejected. The identified peptides were then quantified using Mascot Distiller Toolbox (version 2.5.1.0, MatrixScience) in the precursor mode. All data management was done by ms_lims (Helsens et al., 2010) , and data analysis was performed using R (http://www.R-project.org) embedded in KNIME (Mazanetz et al., 2012) . The median of the peptide ratio distributions of both experiments was corrected to zero. Protein ratios were then calculated by taking the median of the ratio values of peptide spectrum matches that identified that protein. Following this, a 95% confidence interval was determined. Only proteins containing minimal two peptides in one of the experiments were taken into account for data interpretation. Finally, the data were converted using PRIDE Converter (Barsnes et al., 2009 ) and categorized according their function.
Western blotting
Total cell lysates from BMDCs and lysates from isolated phagosomes were subjected to 4%-12% gradient gels (Life Technologies) or 10% and 12% gels and separated by SDS-PAGE. After transfer to nitrocellulose membranes, they were blocked and incubated with primary antibodies and peroxidase-conjugated secondary antibodies. Bound antibodies were revealed using the BM Chemiluminescence Blotting Substrate (POD) from Roche or Amersham according to the manufacturers' directions. The intensity of the bands was quantified by densitometry using Quantity One 4.6.6 software (Bio-Rad) and was expressed as arbitrary units.
Flow Organellocytometry
The flow cytometry techniques used to analyze the capacity of phagosomes to degrade proteins and acquire LAMP-1 have been described previously (Savina et al., 2010; Hoffmann et al., 2012) . In brief, after phagocytosis assays (with a bead:cell ratio of 8:1), cells were washed twice in cold PBS and resuspended in homogenization buffer [3 mM imidazole (pH 7.4), 250 mM sucrose, 2 mM DTT, 2 mM phenylmethylsulfonyl fluoride, 2x protease inhibitor cocktail]. Subsequently, cells were disrupted mechanically with 2-ml syringes and 22-gauge needles (Terumo Medical). Intact cells and nuclei were removed by centrifugation at 150 x g for 4 min at 4 °C, after which post-nuclear supernatant was transferred to 96-well conical-bottom microplates (Greiner). Nonspecific binding sites were blocked by incubation in PBS/1% (vol/vol) BSA, followed by labeling on ice using the afore-mentioned antibodies against OVA and LAMP-1 and/or LAMP-2, and appropriate secondary antibodies. Samples were analyzed with a LSR II and a FACSCalibur flow cytometer (BD Biosciences). External beads were always excluded, when phagosomal degradation of OVA and acquisition of LAMP proteins were analyzed. All flow cytometry data were analyzed using FlowJo software (Tree Star).
Antigen Transport to the Cytosol
BMDCs were loaded with 1 mM of the CCF4-probe (Life Technologies) sensitive to FRET measurements during 30 min. Then cells were washed and incubated at 37°C with 2 mg/ml of purified β-lactamase (SigmaAldrich) for the indicated time points. Live single cells were gated, and the fluorescence intensities of cleaved and uncleaved CCF4 were detected with the 405 nm excitation laser and 450 nm and 535 nm emission filters by flow cytometry. To evaluate the uptake of β-lactamase, BMDCs were incubated with β-lactamase coupled with Alexa Fluor 647 (Life Technologies) and monitored for increasing intensity in the appropriate flow cytometry channel.
siRNA-mediated knockdown of Rab34

siRNA sequences
The following 21 base paired-siRNA sequences specific for Rab34 were purchased (Qiagen): siRNA #1: 5'-CACCTTCGATAAGAATTACAA-3' siRNA #2: 5'-ATGCATTAAAGTCCATTATTA-3' siRNA #3: 5'-CTCCTGCTCAGTATTCCCTAA-3' siRNA #4: 5'-CAAGGTGGCCCAAGAGATTAA-3' As negative control, Scramble All Starts Negative Control (Qiagen) was used.
Dendritic Cell Transfection BMDC transfection was performed by electroporation of resting cells with the afore-mentioned siRNA sequences using the Amaxa Biosystems Nucleofector II electroporator (protocol Y-001 for resting DCs) and Amaxa Mouse Dendritic Cell nucleofector kit (Lonza). Transfection was performed by following manufacturer's instructions with some minor modifications. Briefly, BMDCs were harvested at day 7, resuspended in the electroporation solution provided with the kit. 2 x10 6 cells were distributed per cuvette and electroporated. Cells were quickly plated back in 6-well plates with 3 ml of complete medium. After 24 h, the medium was carefully removed without disturbing the cells and replaced by fresh medium. After 48 h, cells were harvested and subsequently analyzed. In order to control efficacy of transfection, we electroporated the cells with the siRNA together with a GFP-expressing plasmid provided with the kit. After 48 h, more than 85% of the cells analyzed by flow cytometry were positive for GFP for each tested siRNA condition.
Immunofluorescence Assays and Confocal Microscopy
DCs were placed on poly-L-lysine-coated glass coverslips at room temperature during 30 min. After washing with PBS, complete medium was added and the cells were incubated for 30 min at 37°C in an atmosphere of 5% CO 2 . Phagocytosis was performed by adding to the cells 3 µm OVA beads (dilution 1:500) for 1 h at 37°C. After extensive washing with cold PBS, cells were fixed with 2% (vol/vol) paraformaldehyde during 10 min at 4°C and quenched by adding 0.1 M glycine. Cells were permeabilized in PBS containing 0.05% (vol/vol) saponin and 0.2% (vol/vol) BSA for 20 min at room temperature, washed, and incubated first with primary antibodies overnight at 4°C and then with secondary antibodies for 45 min at 4°C. After extensive washing, the coverslips were mounted with Vectashield (Vector Laboratories). Image acquisitions were performed on a Leica TCS SP5 AOBS microscope (Bio Imaging Core facility, VIB, Ghent) equipped with a 63x/1.4 NA oil immersion objective and on a Zeiss confocal LSM 780 microscope equipped with a 40x/1.4 NA oil immersion objective from the PICT-IBiSA@Pasteur microscopy facility (Institute Curie, Paris). Analysis was performed using Fiji software (Schindelin et al., 2012) . For speed of phagosomal migration analysis, beads were tracked for each cell by using TrackMate plugin on the transmission channel. Then F-actin and LAMP-1 fluorescence intensities were measured for each bead position and normalized by the total cell fluorescence intensity using an homemade macro. Another homemade macro was prepared to quantify LAMP-1 relative area for all of the clustering analysis.
Live Imaging of Phago-lysosomal Fusion
BMDCs generated from LifeAct-GFP knock-in mice (kind gift from Michael Sixt, IST, Austria) were loaded with 5 µg/ml WGA Alexa 647 and incubated overnight at 37°C under 5% CO 2 atmosphere. The day after, 3 µm OVA-coated beads were added at a bead:cell ratio of 5:1. The cells were imaged immediately after addition of beads using an epifluorescence Nikon TiE video-microscope equipped with a cooled CCD camera (HQ2, Photometrics) at a frequency of one image every min. Upon movie reconstruction, individual cells were isolated and analyzed using Fiji software (Schindelin et al., 2012) .
Electron microscopy
Resting and LPS-treated BMDCs were fed with 3 µm OVA-coupled beads during 1.5 h (30 min pulse followed by 60 min chase) at 37°C. Subsequently, cells that phagocytosed beads were sorted using a FACSVantage SE cell sorter (BD Biosciences). Sorted cells were extensively washed and fixed in 4% (vol/vol) paraformaldehyde (in 0.1 M PBS) during 2 h at room temperature and analyzed by electron microscopy. Immuno-electron microscopy was performed by the Tokuyasu method (Slot and Geuze, 2007) . Single or double immunogold labeling on ultrathin cryosections was performed using protein A-gold conjugates (PAG) (Utrecht University, Netherlands). A rat anti LAMP-1 antibody (BD Biosciences) was used. Sections were examined using a Tecnai 12 electron microscope (FEI Company) equipped with a digital camera Keen View (SIS).
Statistical Analysis
Statistical calculations and normalizations were performed using Prism 6 software (GraphPad Software Inc.).
